...
首页> 外文期刊>Transplantation Proceedings >PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
【24h】

PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.

机译:PG490-88是一种新型的免疫抑制剂,可有效防止大鼠肾脏同种异体移植的急性和慢性排斥反应。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PG490-88 is a semisynthetic derivative of the novel compound PG490 (triptolide) purified from a Chinese herb. It has been shown to prolong acute allograft survival in multiple experimental organ transplant models. However, the effect of PG490-88 on prevention of acute and chronic renal allograft rejection has not been determined. Kidneys of ACI or F344 rats were transplanted into bilaterally nephrectomized LEW recipients as the acute or chronic allograft rejection models, respectively. Treatment of LEW recipients with PG490-88 significantly prolonged ACI kidney graft survival in a dose-dependent manner when compared with the untreated allograft controls. LEW recipients of F344 kidney grafts who received PG490-88 for 90 days with a brief course of low-dose FK506 showed normal serum creatinine levels and markedly reduced histological changes of chronic rejection at day 90 after transplantation. These results suggest that PG490-88 significantly prolongs kidney allograft survival in an acute rejection model and prevents chronic allograft rejection in rats.
机译:PG490-88是从中草药中纯化得到的新型化合物PG490(雷公藤甲素)的半合成衍生物。在多种实验性器官移植模型中,已证明可延长急性同种异体移植的存活时间。然而,尚未确定PG490-88在预防急性和慢性肾移植排斥反应中的作用。将ACI或F344大鼠的肾脏分别移植为双侧肾切除的LEW受体,作为急性或慢性同种异体移植排斥模型。与未治疗的同种异体移植对照相比,用PG490-88治疗LEW受体可以显着延长ACI肾移植的存活,其剂量依赖性。接受PG490-88短疗程的PG490-88的F344肾移植的LEW受体在移植后90天显示正常的血清肌酐水平,并显着降低了慢性排斥的组织学变化。这些结果表明,PG490-88在急性排斥模型中显着延长了肾脏同种异体移植的存活,并防止了大鼠的慢性同种异体排斥。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号